Efficacy and safety of intranasal haloperidol in an acute Psychiatry Unit: a pilot study on schizophrenic patients with mild-modedate agitation

To study the efficacy and safety of intranasal administration of 5 mg haloperidol on mild-moderate agitated patients with schizophrenia or schizoaffective disorder in an acute psychiatry unit setting.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Actas espanolas de psiquiatria 2021-09, Vol.49 (5), p.205-209
Hauptverfasser:	Duñó Ambròs, Rosó, Oliva Morera, Joan Carles, Iglesias-Lepine, María Luisa, Palao Vidal, Diego, Monreal Ortiz, José Antonio Monreal Ortiz, Labad Arias, Javier
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Intranasal Antipsychotic Agents - adverse effects Antipsychotic Agents - therapeutic use Benzodiazepines - therapeutic use Haloperidol - adverse effects Haloperidol - therapeutic use Humans Pilot Projects Psychiatry Psychomotor Agitation - drug therapy Schizophrenia - drug therapy Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	To study the efficacy and safety of intranasal administration of 5 mg haloperidol on mild-moderate agitated patients with schizophrenia or schizoaffective disorder in an acute psychiatry unit setting.
ISSN:	1139-9287 1578-2735